Pulmonary metastasis risk and overall survival score in choriocarcinoma: a novel nomogram-based risk assessment system

绒毛膜癌肺转移风险和总生存评分:一种基于列线图的新型风险评估系统

阅读:1

Abstract

BACKGROUND: At present, the risk of developing pulmonary metastasis and prognostic factors for choriocarcinoma (CC) remain unclear. This study aimed to investigate the independent risk factors and prognostic factors for pulmonary metastasis of CC and to construct a prognostic prediction model. METHODS: We retrieved data on patients diagnosed with CC between 2010 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regressions were used to identify independent risk factors for developing pulmonary metastases in CC. Then, univariate and multivariate COX regression analyses were used to identify independent risk factors affecting the prognosis of patients with CC. Finally, we constructed a predictive nomogram and assessed the efficacy of the nomogram by receiver operating characteristic (ROC) curves, calibration curves, and decision analysis curves (DCAs). RESULTS: Independent risk factors for developing pulmonary metastases in CC patients were gender and tissue type. Independent risk factors for the prognosis of CC patients were age, marriage, primary location, liver metastases, lung metastases, and surgical intervention. The results of ROC curves, calibration curves, and DCA in the training and validation groups confirmed that the nomogram could accurately predict the prognosis of CC patients. CONCLUSIONS: Patients with CC are more likely to be young, have a more primary male genital system, have a poor prognosis, and are most likely to be complicated by pulmonary metastasis at initial diagnosis. A novel prediction model to predict the prognosis of CC patients has been constructed to personalize and guide clinical decision-making.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。